- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fuji taps Strauss for increased role
Fuji taps Strauss for increased roleFuji Medical Systems USA has promoted company veteran John Strauss to director of marketing for the Stamford, CT-based firm's newly formed imaging and information networks division, which was launched to
Fuji taps Strauss for increased role
Fuji Medical Systems USA has promoted company veteran John Strauss to director of marketing for the Stamford, CT-based firm's newly formed imaging and information networks division, which was launched to oversee the development and introduction of its Synapse PACS product line (
PNN
12/97). Strauss, who has served as Fuji's national marketing manager for more than seven years, will also continue to oversee the company's CR marketing efforts.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
